[Treatment of hyperuricemia and gout based on the guideline for the management of hyperuricemia and gout].
amtanigu@ior.twmu.ac.jp
Atsuo
A
Taniguchi
D000493:Allopurinol / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D001553:Benzbromarone / Q000008:administration & dosage; D003078:Colchicine / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006073:Gout / Q000209:etiology / Q000628:therapy*; D006074:Gout Suppressants / Q000008:administration & dosage; D006801:Humans; D033461:Hyperuricemia / Q000209:etiology / Q000628:therapy*; D008019:Life Style; D024821:Metabolic Syndrome / Q000150:complications; D017410:Practice Guidelines as Topic; D011339:Probenecid / Q000008:administration & dosage; D014528:Uricosuric Agents / Q000008:administration & dosage
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D006074:Gout Suppressants; D014528:Uricosuric Agents; D001553:Benzbromarone; D000493:Allopurinol; D011339:Probenecid; D003078:Colchicine